Navigation Links
Transplant Program Tops in Expected One-Year Survival Rate

SEATTLE, Jan. 22 /PRNewswire/ -- Fred Hutchinson Cancer Research Center's stem-cell transplant program at the Seattle Cancer Care Alliance (SCCA) was one of only two transplant programs nationwide that consistently outperformed the expected one-year survival rate for unrelated donor transplants, according to an independent report that assessed 122 transplant centers over a five-year period.

The Center for International Blood and Marrow Transplant Registry examined the survival rates of 8,847 transplants performed to treat blood cancers at U.S. centers in the National Marrow Donor Program (NMDP) network. The survival data was collected for the years 2002 through 2006 and patient outcomes were measured at the end of 2007. In each of five years, the Hutchinson Center "over performed" in terms of expected one-year survival rates after transplant. Only one other transplant center in the nation matched that record. The data was adjusted for several risk factors that could influence patient outcomes such as type of disease, its stage, patient age and degree of donor cell match.

Stem-cell and bone-marrow transplants are used to treat various leukemias, lymphomas and severe aplastic anemia.

"The study's findings reflect the extraordinary and longtime dedication by the staff of the Hutchinson Center and SCCA to improve the outcomes of our patients by continually refining transplantation to be a safer and more effective treatment," said Fred Appelbaum, M.D., executive director of the SCCA and director of the Hutchinson Center's Clinical Research Division.

The clinical use of bone-marrow and stem-cell transplantation was first developed at the Hutchinson Center and, subsequently, most of its practitioners were trained there. Patients who choose to have their transplants done at centers that do a high number of such procedures generally have better outcomes.

Required by federal law, the registry's annual report is designed to provide potential stem-cell transplant recipients, their families and the public with comparative survival rates among the transplant centers in the NMDP network.

About Seattle Cancer Care Alliance

Seattle Cancer Care Alliance, established in 1998, unites the adult and pediatric cancer-care services of Fred Hutchinson Cancer Research Center, UW Medicine and Children's Hospital and Regional Medical Center. A major focus of SCCA is to speed the transfer of new diagnostic and treatment techniques from the research setting to the patient bedside while providing premier, patient-focused cancer care. Patients who come to SCCA receive the latest research-based cancer therapies as well as cutting-edge treatments for a number of non-malignant diseases under development by its partner organizations. SCCA has three clinical-care sites: an outpatient clinic on the Fred Hutchinson campus, a pediatric-inpatient unit at Children's and an adult-inpatient unit at UW Medical Center. For more information about SCCA, visit

Media Contact:

Dean Forbes, (206) 667-289

SOURCE Seattle Cancer Care Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program
2. Transplanted cells may hold the key to curing hemophilia A, Einstein scientists report
3. New Independent Research Study Indicates That Cylexs ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection
4. Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection
5. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
6. Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkins Lymphoma
7. Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop Designer Transplants
8. The First Ever Transplantation World-Wide of Entire Arms at the "Klinikum rechts der Isar" in Munich
9. AST Endorses Istanbul Declaration to End Organ Trafficking and Transplant Tourism
10. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
11. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
Post Your Comments:
(Date:6/27/2016)... DIEGO , June 27, 2016  Sequenom, Inc. ... committed to enabling healthier lives through the development of ... Court of the United States ... courts that the claims of Sequenom,s U.S. Patent No. ... patent eligibility criteria established by the Supreme Court,s Mayo ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight ... solutions to the healthcare market. The company's primary focus is on new product ... marketing strategies that are necessary to help companies efficiently bring their products to ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):